Despite Goal Directed Fluid Therapy (GDFT) has shown a reduction of hospitalization and overall complications in patients undergoing abdominal surgery, there is a need to address the effect of implementing GDFT on the incidence of specific surgical complications and in a context of en enhanced recovery program (ERP). Specifically, studies investigating the impact of GDFT on primary postoperative ileus (POI) in patients undergoing laparoscopic colorectal surgery and using an ERP are missing. It is hypothesized that the incidence of primary POI will be reduced in patients receiving intraoperative GDFT compared to patients receiving Standard Fluid Therapy (SFT) after elective laparoscopic colorectal surgeries with an ERP program.
Randomized Controlled Trial. Study population: elective laparoscopic colorectal resections with an Enhanced Recovery Program (ERP) Sample size: 128 patients (140 accounting for drops out) Two arms: GDFT: patients will receive GDFT esophageal doppler guided; SFT: patients will receive SFT based on standard anesthesia formula and international guidelines to calculate fluid requirements. Study Hypothesis: the incidence of primary POI will be reduced in patients receiving intraoperative GDFT compared to patients receiving SFT after elective laparoscopic colorectal surgeries with an ERP program. ERP: all patients will receive the same perioperative care according to the Enhanced Recovery After Surgery ERAS® program guidelines. Intravenous fluid will be stopped the first day after surgery. Patients will be allowed to have clear fluids the same day of surgery and diet, as tolerated, the first day after surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
128
Montreal General Hospital
Montreal, Quebec, Canada
Primary postoperative ileus (POI)
Patients will be considered having primary POI if at least one symptom, for each of the following criteria, will be reported: i. vomiting (+/- nausea) OR abdominal distension AND ii. Absence of passing gas/stool OR not tolerating oral diet.
Time frame: participants will be followed for the duration of hospital stay, an expected average of 3 days
Intraoperative hemodynamic measurements
Systolic blood pressure; diastolic blood pressure; mean arterial blood pressure; heart rate; flow-time corrected (FTc); stroke distance (SD); Peak velocity (PV); stroke volume (SV); stroke index (SVI); cardiac output (CO); cardiac Index (CI)
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
Intraoperative and postoperative fluids and blood products required
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
Vasoactive agents required
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
Urinary output
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
Intraoperative and postoperative urinary output
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
Intraoperative and Postoperative opioid consumption
Intraoperative opioid administration and postoperative opioid consumption
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
Postoperative nausea and vomiting (PONV)
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
Time spent out of bed
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
Postoperative complications (Clavien Classification)
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
Patients' weight
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
Quality of surgical recovery score
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
Readiness to be discharged
: according to the colorectal pathway, hospital discharge is planned on postoperative day 3. Patients will be discharged if afebrile, able to tolerate oral diet, pain is controlled (NRS \< 4), and able to ambulate
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
Length of hospital stay
Time frame: Participants will be followed for the duration of hospital stay, an expected average of 3 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.